… There are limited and inconsistent data in NET on molecular markers that have been
associated with response to checkpoint inhibitors such as PD-1 or PDL-1 staining in …

… Novel requirements are necessary to develop … of multiple molecular markers and predictive
nomograms that interface biological variables to delineate disease progress or treatment …

… PRRT is a novel therapy and investigations regarding its efficacy are ongoing. One series
of 504 patients with gastroenteropancreatic NETs treated with Lu-177 labeled PRRT reported …

… in pancreatic cancer therapy, and we propose a novel strategy … anticancer genes to the site
of pancreas. We aim to provide a … and endocrine tumors can develop from different pancreatic …

… Hence, increased understanding of the interaction between tumor buds and the TME
could improve PC classification and guide the development of novel therapeutic strategies. …

… Neuroendocrine tumors (NETs) are rare neoplasms arising from the neuroendocrine cells. …
Overview of the most relevant molecular pathways and targeted therapeutic strategies in NET …

… has become an increasing important novel therapeutic approach, therefore identifying useful
molecular markers to predict prognosis and therapeutic response is of increasing clinical …

… markers might serve as outcome predictors and potential therapeutic targets in colorectal
cancer. … summary of therapeutic compounds capable of targeting EMT markers, including drugs …

… molecular factors playing role on development of prostate carcinoma and novel treatment
strategies … interest over recent years as a novel therapeutic target in cancer. In this paper it is …

… Our results suggest that the agent BYL719 could be a novel therapeutic approach to the
treatment of NETs that may sensitize NET cells to somatostatin analogs, and that if there is …